Q4 2014 13F Holders as of 12/31/2014
-
Type / Class
-
Equity / COM
-
Shares outstanding
-
192M
-
Number of holders
-
336
-
Total 13F shares, excl. options
-
148M
-
Shares change
-
+1.09M
-
Total reported value, excl. options
-
$13.3B
-
Value change
-
+$113M
-
Put/Call ratio
-
0.51
-
Number of buys
-
150
-
Number of sells
-
-158
-
Price
-
$90.40
Significant Holders of BIOMARIN PHARMACEUTICAL INC - COM (BMRN) as of Q4 2014
391 filings reported holding BMRN - BIOMARIN PHARMACEUTICAL INC - COM as of Q4 2014.
BIOMARIN PHARMACEUTICAL INC - COM (BMRN) has 336 institutional shareholders that have filed 13F forms with the Securities Exchange Commission (SEC).
These institutions hold a total of 148M shares
of 192M outstanding shares and own 76.99% of the company stock.
Largest 10 shareholders include Capital Research Global Investors (18.1M shares), FMR LLC (13.4M shares), SANDS CAPITAL MANAGEMENT, LLC (12.2M shares), VANGUARD GROUP INC (8.85M shares), PRIMECAP MANAGEMENT CO/CA/ (8.02M shares), JENNISON ASSOCIATES LLC (5.66M shares), BAKER BROS. ADVISORS LP (3.71M shares), BlackRock Institutional Trust Company, N.A. (3.53M shares), BlackRock Fund Advisors (2.95M shares), and BLAIR WILLIAM & CO/IL (2.7M shares).
This table shows the top 336 institutional shareholders of the company equity. This data is sourced directly from the SEC via 13F filings.
| Investor |
Option |
Weight % |
Change % |
Value $ |
* Price $ |
Shares |
Share Change |
Activity |
Report Period |
* Reported Price is the price of the security as of the portfolio date. This value is significant in that it is the last known price at which the security was still held.
An asterisk sign (*) next to the price indicates that the price is likely invalid.